Wegovy (semaglutide for weight management) Available doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg weekly
Decreased appetite is technically a side effect (reported by 5-9%) though most patients consider it the desired therapeutic effect
Weight loss alone boosts HDL by improving the cholesterol-to-HDL ratio, a key marker of cardiovascular risk
(While not unique to compounded drugs, the FDA also permits some unapproved prescription drugs to be marketed when health care professionals rely on the drug to treat serious medical conditions and there is no FDA-approved option.) However, with regard to the Willow post, its worth noting that GLP-1 drugs have only been approved to treat diabetes or weight loss, not alcohol problems
Whether youre just starting out or adjusting your current dose, its all about finding an amount where the benefits outweigh the side effects